| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$36,806 |
Update - Notification of buy-back - ALL
|
4 Jun 2026 8:29AM |
$51.000 |
$61.400 |
risen by
20.39%
|
|
| Nexus Minerals Limited (NXM) ORDINARY FULLY PAID |
Materials |
$28 |
High Grade Results at Payns Prospect up to 19.00g/t Au
|
4 Jun 2026 8:29AM |
$0.059 |
$0.047 |
fallen by
20.34%
|
|
NXM - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade assay results up to 19.00g/t Au at Payns Prospect.
- Results part of a 22,000m RC drilling program at Wallbrook Gold Project.
- Continuous near-surface mineralisation system identified.
- Potential for lateral and vertical growth of the resource.
- Drilling results support potential for a maiden Mineral Resource Estimate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$218 |
Notification of cessation of securities - SKY
|
4 Jun 2026 8:28AM |
$0.245 |
$0.220 |
fallen by
10.20%
|
|
| Argo Investments Limited (ARG) ORDINARY FULLY PAID |
Financials |
$6,772 |
Update - Notification of buy-back - ARG
|
4 Jun 2026 8:27AM |
$8.860 |
$9.000 |
risen by
1.58%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$23 |
PainChek secures initial Sabra US care facilities
|
4 Jun 2026 8:27AM |
$0.140 |
$0.110 |
fallen by
21.43%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$38 |
Update - Notification of buy-back - MEC
|
4 Jun 2026 8:27AM |
$1.310 |
$1.255 |
fallen by
4.20%
|
|
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$29 |
Commercial Momentum Presentation
|
4 Jun 2026 8:27AM |
$0.059 |
$0.064 |
risen by
8.47%
|
|
CBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Control Bionics Limited (CBL), a global neurotechnology company, is focused on commercialising non-invasive neural-signal technology.
- The company's strategy involves scaling its neural-signal technology platform across markets, including assistive communication, neurotech solutions, and platform and medical technologies.
- In Assistive Technology, the NeuroNode has received significant validation in the US with dedicated E2513 HCPCS code, facilitating broader adoption and a shift to a wholesale distribution model.
- Partnerships with Tobii Dynavox and PRC-Saltillo have been initiated to expand US distribution for the NeuroNode.
- The company has signed a Letter of Intent for iOS-based speech-generating devices with an anticipated rollout in July 2026.
- In NeuroTech Solutions, the NeuroStrip is being applied in sports performance, rehabilitation, and clinical use cases, with various partnerships in Australia and the US.
- Control Bionics is engaging in trials with sports teams and rehabilitation clinics, including Royal Rehab in Australia, Ohio University, and Mayo Clinic in the US.
- The Platform and Medical Technologies pillar is seeing progress with Apple BCI integration and research partnerships with institutions like Mayo Clinic and Penn State Health.
- Control Bionics is positioning itself as a leader in non-invasive neural-signal technology and aims to convert customer momentum into scalable commercial outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Control Bionics Limited (CBL) ORDINARY FULLY PAID |
Health Care |
$29 |
Commercial Momentum, Execution and Market Access Update
|
4 Jun 2026 8:25AM |
$0.059 |
$0.064 |
risen by
8.47%
|
|
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$95 |
Update - Notification of buy-back - ARA
|
4 Jun 2026 8:25AM |
$0.480 |
$0.500 |
risen by
4.17%
|
|
| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$103 |
Update - Notification of buy-back - HPG
|
4 Jun 2026 8:25AM |
$0.735 |
$0.755 |
risen by
2.72%
|
|
| Orica Limited (ORI) ORDINARY FULLY PAID |
Materials |
$10,777 |
Appointment of Director
|
4 Jun 2026 8:25AM |
$23.070 |
$23.250 |
risen by
0.78%
|
|
| Felix Gold Limited (FXG) ORDINARY FULLY PAID |
Materials |
$127 |
Extraction Commences at High-Grade US Antimony Project
|
4 Jun 2026 8:25AM |
$0.310 |
$0.245 |
fallen by
20.97%
|
|
FXG - Price-sensitive ASX Announcement
Full Release
Key Points
- Felix Gold Limited commences extraction and stockpiling at Treasure Creek Antimony Project.
- Project located in Fairbanks Mining District, Alaska, significant for U.S. antimony supply.
- Approximately 30 tonnes of high-grade stibnite extracted under approved bulk sample permit.
- Project part of the State of Alaska's coordinated permitting process.
- Successful logistics demonstrated by transporting 20 tonnes to off-site storage.
- Exploration of processing pathways for potential early revenue generation.
- Board approved long-term incentive options for Executive Director, subject to shareholder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ventia Services Group Limited (VNT) ORDINARY FULLY PAID |
Industrials |
$4,882 |
Update - Notification of buy-back - VNT
|
4 Jun 2026 8:24AM |
$6.240 |
$5.970 |
fallen by
4.33%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,422 |
Update - Notification of buy-back - WHC
|
4 Jun 2026 8:24AM |
$9.250 |
$7.810 |
fallen by
15.57%
|
|
| Propel Funeral Partners (PFP) ORDINARY FULLY PAID |
Consumer Discretionary |
$432 |
Acquisitions and FY26 Guidance
|
4 Jun 2026 8:24AM |
$3.540 |
$3.130 |
fallen by
11.58%
|
|
PFP - Price-sensitive ASX Announcement
Full Release
Key Points
- Propel Funeral Partners announces three acquisitions in New Zealand.
- The acquisitions total up to approximately AUD 9.1 million.
- Completion expected in Q4 FY26 or Q1 FY27.
- FY26 revenue guidance between AUD 225 million and AUD 230 million.
- Operating EBITDA for FY26 expected between AUD 54.5 million and AUD 56.5 million.
- Stable gross margins and operating cost increases of about 2.5% anticipated.
- Foreign exchange impacts due to a strengthening Australian dollar expected to affect revenue and operating EBITDA.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$5,995 |
Update - Notification of buy-back - APE
|
4 Jun 2026 8:24AM |
$20.330 |
$21.230 |
risen by
4.43%
|
|
| Temple & Webster Group Ltd (TPW) ORDINARY FULLY PAID |
Consumer Discretionary |
$579 |
Update - Notification of buy-back - TPW
|
4 Jun 2026 8:24AM |
$4.810 |
$4.970 |
risen by
3.33%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$32 |
Rhythm Bio Singapore Investor Presentation
|
4 Jun 2026 8:24AM |
$0.115 |
$0.090 |
fallen by
21.74%
|
|
| Pro Medicus Limited (PME) ORDINARY FULLY PAID |
Health Care |
$16,938 |
PME signs 5-year, A$16M contract renewal with OSU
|
4 Jun 2026 8:24AM |
$159.630 |
$162.130 |
risen by
1.57%
|
|
PME - Price-sensitive ASX Announcement
Full Release
Key Points
- PME signs 5-year, A$16M contract renewal with OSUWMC.
- Contract includes Visage 7 Workflow and Visage 7 Cardiology Imaging.
- The transaction-based model presents potential upside.
- Renewal involves increased minimums and fee per transaction.
- Pro Medicus highlights client retention and return on investment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nufarm Limited (NUF) ORDINARY FULLY PAID |
Materials |
$1,091 |
Ceasing to be a substantial holder
|
4 Jun 2026 8:24AM |
$2.850 |
$2.840 |
fallen by
0.35%
|
|
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$5,182 |
Update - Notification of buy-back - AMP
|
4 Jun 2026 8:24AM |
$1.500 |
$2.130 |
risen by
42%
|
|
| PMET Resources Inc (PMT) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$321 |
PMET Receives Letter of Interest for Project Financing
|
4 Jun 2026 8:24AM |
$0.750 |
$0.475 |
fallen by
36.67%
|
|
PMT - Price-sensitive ASX Announcement
Full Release
Key Points
- PMET Resources Inc. received a non-binding Letter of Interest from Société Générale.
- The LOI is for potential financing of the Shaakichiuwaanaan Project in Quebec.
- Société Générale may act as Mandated Lead Arranger for the debt financing.
- The LOI is preliminary, non-binding, and conditional.
- PMET aims to complete an updated Feasibility Study by Q4 2026.
- The Shaakichiuwaanaan Project is significant for lithium and caesium resources.
- PMET continues to build a financing syndicate for Phase 1 development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Valiant Gold Limited (VAL) ORDINARY FULLY PAID |
Materials |
$60 |
Accelerating Mine Restart Activities
|
4 Jun 2026 8:23AM |
$0.240 |
$0.200 |
fallen by
16.67%
|
|
| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$20,625 |
Update - Notification of buy-back - REA
|
4 Jun 2026 8:23AM |
$158.300 |
$157.610 |
fallen by
0.44%
|
|
| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$218 |
Change of Director's Interest Notice - Richard Hill
|
4 Jun 2026 8:23AM |
$0.245 |
$0.220 |
fallen by
10.20%
|
|
Call 1300 880 160
Start a chat
Schedule a call
